Senior Principal Scientist supporting nonclinical safety strategies for Degrader - Antibody Conjugate (DAC) programs. Overseeing toxicology studies, regulatory submissions, and cross - functional collaborations.

Orum Therapeutics is an oncology-focused, private, clinical stage biotech pioneering the development of antibody-enabled, dual-precision targeted protein homeostasis.
We leverage our TPD² approach to provide targeted protein degraders, and TPS² approach to provide targeted protein stabilizers for cell-specific delivery to improve patient outcomes.
Orum is located in Lexington, MA, USA and Daejeon, South Korea.
Browse and apply for open jobs at Orum Therapeutics.
Senior Principal Scientist supporting nonclinical safety strategies for Degrader - Antibody Conjugate (DAC) programs. Overseeing toxicology studies, regulatory submissions, and cross - functional collaborations.